Navigation Links
Lentiviral Vector Manufacture from Lentigen

ProductsLentiviral Vector Manufacture from Lentigen
Company Lentigen
Item Lentiviral Vector Manufacture
Price 
Description Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer and purity. • Starting at $2,450
Info LentigenLentigen
1450 South Rolling Road
Baltimore, Maryland 21227
U.S.
Customer Service: 1.877.MY.LENTI (1.877.695.3684), or 443.543.5314
Fax Number: 443.543.5332
Web Site: http://www.lentigen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. ViraPower Lentiviral Packaging Mix from Invitrogen
2. ViraPower UbC Lentiviral Gateway Expression Kit from Invitrogen
3. pMIR-mU6-Luc, Mouse U6 Luciferase Control Vector from Mirus Bio Corporation
4. pMIR-mU6, Mouse U6Template (Vector) from Mirus Bio Corporation
5. pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation
6. LabShare 3.0 for Vector NTI Data Management Software from Invitrogen
7. pYD1 Yeast Display Vector from Invitrogen
8. pSTBlue-1 AccepTor Vector Kit from Novagen
9. ImmEdge Hydrophobic Barrier Pen from Vector Laboratories
10. pBICEP-CMV-3 Expression Vector from Sigma-Aldrich
11. pAcAB4 Baculovirus Transfer Vector from BD Biosciences Pharmingen
...loped the Easy-Titer Human IgM Assay Kit to addres...rform assay for Human IgM that eliminates the need...and-read assay that allows the accurate determinat...oximately 30 minutes. The Pierce Easy-Titer Human ...
...ilizer is an aqueous solution that contains a puri...g chemicals in a saline solution, pH 6.5 7.5, and...ne and 0.02% bromonitrodioxane as a preservative. ...bilizer for biologically active components in solu...
Cleanascite HC 16000 from Biotech Support Group
...e Stabilizer is a bovine protein-free alternative ...ueous solution that contains non-toxic chemicals i... - 7.2, and does not contain a preservative. This...other biomolecules that are absorbed or immobilize...
Biology Products:
(Date:11/23/2009)...n Society says that western lowland gorillas livin... the "mother lode" of more than 125,000 gorillas d...tened by growing humans activity in the region. ,...ests adjacent to the southwest border of Lac Tl Co...t high densities of the great apes still exist in ...
(Date:11/23/2009)...the highest resolution images of peptides attachin...derstanding how biomolecules manipulate the growth...nt for kidney stones using biomolecules. , The r...on of the journal Proceedings of the National Aca...with mineral surfaces by accelerating, switching a...
(Date:11/23/2009)...dical engineer and cardiologist Tzung "John" Hsiai...stinguish cardiac emergencies requiring immediate ...s and lifestyle change. , Angiograms, images mad...the heart, offer an inside view of the interior su...aling deposits of a dangerous fatty substance call...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Gene Therapy Brings New Muscle to Monkeys 61251 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 2Coffee break 3A Compound brewing new research in colon breast cancer 61247 3Coffee break 3A Compound brewing new research in colon breast cancer 61247 4Coffee break 3A Compound brewing new research in colon breast cancer 61247 5Coffee break 3A Compound brewing new research in colon breast cancer 61247 6Discoveries at NJIT including drug to stop brain injury receives 241 4M funding 61243 1Discoveries at NJIT including drug to stop brain injury receives 241 4M funding 61243 2
...dies against the Epstein-Barr virus, the virus tha...ely to develop multiple sclerosis 15 to 20 years l...t will appear in the June 2006 print issue of Arch...ls. , Researchers have long suspected that externa...rosis (MS), a chronic autoimmune disease that affe...
...lled statins do not appear to reduce the incidence...nalysis of previous studies in the January 4 issue...ins reduce the risk of developing cancer, the auth...w article. "Statins have been studied in numerous...olled trials for primary and secondary prevention ...
...frican sleeping sickness (trypanosomiasis). Resear...for Biotechnology (VIB) connected to the Free Univ...e against this disease. , They have coupled the h...ry specifically eliminate the infection caused by ...e mechanism is powerless. Tests on mice are alread...
Other Biology News:Big hips, big belly? It's in your genes, Joslin-led study shows 2Statins have neutral effect on risk of cancer 2A large step forward in the fight against African sleeping sickness 2
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4